Evaluation of Cefixime-Clavulanate Combination by Comparative Disk Diffusion Method in Klebsiella pneumoniae Clinical Isolates-An In-Vitro Study
Journal Title: Journal of Krishna Institute of Medical Sciences University - Year 2015, Vol 4, Issue 2
Abstract
Background: Resistance to cephalosporins due to β-lactamases is a major concern worldwide. However recent trend is to use β-lactamase inhibitor combinations. Potential combination is cefiximeclavulanate. Objective: Present study aims at the comparative evaluation of Fixed-Dose Combination (FDC) of cefixime‑clavulanate and cefixime-alone in Klebsiella pneumoniae clinical isolates. Material and Methods: Study included 200 clinical isolates of K. pneumoniae. The Comparative Antimicrobial Susceptibility Test (AST) of cefixime‑clavulanate (5µg/10µg) combination and cefixime-alone(5µg) was done by measurement and comparison of zone of lysis produced by both. All values were expressed in mean ± SD. Paired‘t’ test was used to determine statistical difference between different groups under study. P values < 0.05 were considered statistically significant. Isolates were tested for ExtendedSpectrum β-lactamase (ESBL), AmpC β-lactamase (AmpC) and metallo β-lactamase (MBL) production by Clinical Laboratory Standards Institute - Phenotypic Disk Confirmatory Test (CLSI-PDCT), AmpC β-lactamase sterile disk test and Imipenem-Ethylene Di-amine Tetracetic Acid – Double disk synergy test (Imipenem-EDTA DDST) respectively. Results: Comparative AST resulted in statistically significant (P < 0.001) increased zones in cefixime‑clavulanate combination than cefixime-alone in all isolates studied. When zones were evaluated separately only in three β-lactamase producing isolates; cefiximeclavulanate combination showed much higher zones in ESBL-producers (n=30) (P < 0.001), but not in AmpC-producers (n=32) (P = 0.5559) and MBLproducers (n=06) (P = 0.7815). Conclusion: Present study demonstrates the best bactericidal killing effect of cefixime-clavulanate compared to cefixime-alone. It is also of therapeutic significance in the treatment of infections caused by K. pneumoniae producing ESBLs. We recommend comparative AST method when commercially available newer β-lactamase inhibitor combination, for which no CLSI interpretive guidelines are available; to be studied systematically, before implementing it in treatment regimen.
Authors and Affiliations
Gajul S. V , Mohite S. T , Kakade S. V , Mangalagi S. S , Wavare S. M
Keywords
Related Articles
- EP ID EP105782
- DOI -
- Views 99
- Downloads 0
Persistent Mullerian Duct Syndrome Presenting As Transverse Testicular Ectopia [TTE] Rarest of Rare: A Case Report
Persistent Mullerian Duct Syndrome (PMDS) is usually an accidental finding either during orchipexy or during routine inguinal hernia repair in male patients presenting with mal- descended testes. It is caused by a de...
Large Disappearing Mullerian Cyst on Posterior Vaginal Wall: Report of a Rare Case
Cystic lesions of vagina are relatively uncommon and an incidental finding during routine gynaecological examination. Mullerian cysts are congenital cysts of vagina, usually reported during childbearing age group. Th...
Fast Foods and their Impact on Health
Eat healthy and live healthy is one of the essential requirements for long life. Unfortunately, today’s world has been adapted to a system of consumption of foods which has several adverse effects on health. Lifestyle ch...
Analysis of Gastric Juice in Acid Peptic Diseases
Background: Peptic ulcer disease is an imbalance between offensive and defensive gastric factors. A bacterium called Helicobacter pylori has been considered a major causative agent for gastric and duodenal ulcers. Th...
Gastric Glomus Tumour-A Rare Case Report
Gastric glomus tumour is a rare benign mesenchymal neoplasm composed of modified smooth muscle cells and neoplastic counter part of perivascular glomus body. Commonest site of glomus tumour being distal extremities (Subu...